Globus Medical, which sells spine implants to hospitals for use in surgical procedures, raised $100 million by offering 8.3 million shares at $12.00, the low end of the revised range of $12.00 to $13.00. The company had previously filed to sell 11.8 million shares at a price range of $16.00 to $18.00. Globus Medical plans to list on the NYSE under the symbol GMED. BofA Merrill Lynch, Goldman Sachs and Piper Jaffray acted as lead managers on the deal.
